Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Buti

Showing results (31-40 of 335) with videos related to

Pageof 34
Sort By:
The Lancet. Oncology|December 25, 2019
Unlocking the secret of the obesity paradox in renal tumoursMatteo Santoni, Alessio Cortellini, Sebastiano Buti
Acta Bio-Medica : Atenei Parmensis|June 6, 2014
A wide skull ostelytic metastasis in advanced breast cancerSebastiano Buti, Anselmo Alessandro Palumbo, Angelica Sikokis
Acta Bio-Medica : Atenei Parmensis|February 12, 2013
A new modified schedule of sunitinib for metastatic renal cell carcinoma: a retrospective analysisSebastiano Buti, Maddalena Donini, Silvia Lazzarelli, et al.
Critical Reviews in Oncology/Hematology|March 5, 2021
Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literatureGiulia Mazzaschi, Federico Quaini, Melissa Bersanelli, et al.
Therapeutics and Clinical Risk Management|July 20, 2017
Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinomaAlessandro Leonetti, Francesco Leonardi, Melissa Bersanelli, et al.
World Journal of Nephrology|February 4, 2022
Renal cell carcinoma and viral infections: A dangerous relationship?Melissa Bersanelli, Chiara Casartelli, Sebastiano Buti, et al.
The Lancet. Oncology|June 9, 2017
"Finding NEMO" in NRAS-mutant melanoma: a step towards a sequential strategy?Melissa Bersanelli, Alessandro Leonetti, Sebastiano Buti, et al.
Thoracic Cancer|December 12, 2018
Family history of cancer and DNA damage response genes: Two sides of the same coin?Alessio Cortellini, Melissa Bersanelli, Corrado Ficorella, et al.
Core Evidence|September 14, 2016
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapySebastiano Buti, Alessandro Leonetti, Alice Dallatomasina, et al.
Targeted Oncology|May 11, 2019
The Urinary Microbiome and Anticancer Immunotherapy: The Potentially Hidden Role of Unculturable MicrobesMelissa Bersanelli, Matteo Santoni, Andrea Ticinesi, et al.
Pageof 34

Showing results (31-40 of 335) with videos related to

Sort By:
Pageof 34
The Lancet. Oncology|December 25, 2019
Unlocking the secret of the obesity paradox in renal tumoursMatteo Santoni, Alessio Cortellini, Sebastiano Buti
Acta Bio-Medica : Atenei Parmensis|June 6, 2014
A wide skull ostelytic metastasis in advanced breast cancerSebastiano Buti, Anselmo Alessandro Palumbo, Angelica Sikokis
Acta Bio-Medica : Atenei Parmensis|February 12, 2013
A new modified schedule of sunitinib for metastatic renal cell carcinoma: a retrospective analysisSebastiano Buti, Maddalena Donini, Silvia Lazzarelli, et al.
Critical Reviews in Oncology/Hematology|March 5, 2021
Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literatureGiulia Mazzaschi, Federico Quaini, Melissa Bersanelli, et al.
Therapeutics and Clinical Risk Management|July 20, 2017
Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinomaAlessandro Leonetti, Francesco Leonardi, Melissa Bersanelli, et al.
World Journal of Nephrology|February 4, 2022
Renal cell carcinoma and viral infections: A dangerous relationship?Melissa Bersanelli, Chiara Casartelli, Sebastiano Buti, et al.
The Lancet. Oncology|June 9, 2017
"Finding NEMO" in NRAS-mutant melanoma: a step towards a sequential strategy?Melissa Bersanelli, Alessandro Leonetti, Sebastiano Buti, et al.
Thoracic Cancer|December 12, 2018
Family history of cancer and DNA damage response genes: Two sides of the same coin?Alessio Cortellini, Melissa Bersanelli, Corrado Ficorella, et al.
Core Evidence|September 14, 2016
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapySebastiano Buti, Alessandro Leonetti, Alice Dallatomasina, et al.
Targeted Oncology|May 11, 2019
The Urinary Microbiome and Anticancer Immunotherapy: The Potentially Hidden Role of Unculturable MicrobesMelissa Bersanelli, Matteo Santoni, Andrea Ticinesi, et al.
Pageof 34